A three-gene signature from protein-protein interaction network of LOXL2 - and actin-related proteins for esophageal squamous cell carcinoma prognosis

Integrated genomic characterization of oesophageal carcinoma

(2017)   NATURE

Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma

(2017) C-Q Li et al.   Oncogenesis

National estimates of cancer prevalence in China, 2011

(2016) Rongshou Zheng et al.   CANCER LETTERS

Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013

(2016) Maigeng Zhou et al.   LANCET

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma

(2015) Yoshihiro Morita et al.   CLINICAL & EXPERIMENTAL METASTASIS

Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression

(2015) A. Martin et al.   EMBO JOURNAL

Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma

(2015) Shinya Ohashi et al.   GASTROENTEROLOGY

E-cadherin junctions as active mechanical integrators in tissue dynamics

(2015) Thomas Lecuit et al.   NATURE CELL BIOLOGY

Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma

(2014) Guo-Qing Lv et al.   Biochemistry and Cell Biology

Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer

(2014) Hiroaki Kasashima et al.   CANCER LETTERS

A Proteome-Scale Map of the Human Interactome Network

(2014) Thomas Rolland et al.   CELL

Sensing the local environment: actin architecture and Hippo signalling

(2014) Pedro Gaspar et al.   CURRENT OPINION IN CELL BIOLOGY

LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma

(2014) Jiagen Li et al.   GUT

Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma

(2014) Carmen Chak-Lui Wong et al.   HEPATOLOGY

LOXL2 Status Correlates with Tumor Stage and Regulates Integrin Levels to Promote Tumor Progression in ccRCC

(2014) H. Hase et al.   MOLECULAR CANCER RESEARCH

Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization

(2014) G Canesin et al.   ONCOGENE

Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma

(2013) Wenjun Chang et al.   GUT

E-cadherin-integrin crosstalk in cancer invasion and metastasis

(2013) M. Canel et al.   JOURNAL OF CELL SCIENCE

Targeting protein–protein interactions as an anticancer strategy

(2013) Andrei A. Ivanov et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Actin binding proteins

(2013) Stephane R. Gross   Cell Adhesion & Migration

Differential Remodeling of Actin Cytoskeleton Architecture by Profilin Isoforms Leads to Distinct Effects on Cell Migration and Invasion

(2012) Ghassan Mouneimne et al.   CANCER CELL

A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

(2012) I. Garcia et al.   CLINICAL CANCER RESEARCH

LOXL2 in epithelial cell plasticity and tumor progression

(2012) Amparo Cano et al.   Future Oncology

RETRACTED: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3

(2012) Nicolás Herranz et al.   MOLECULAR CELL

Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma

(2011) Fredrik Jerhammar et al.   CANCER BIOLOGY & THERAPY

Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical Phenotypes

(2011) H. Su et al.   CLINICAL CANCER RESEARCH

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

(2011) Gema Moreno-Bueno et al.   EMBO Molecular Medicine

Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase–like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma

(2011) Tian-Yu Li et al.   HUMAN PATHOLOGY

Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening

(2010) E Ruiz-Garcia et al.   BRITISH JOURNAL OF CANCER

Cell mechanics and the cytoskeleton

(2010) Daniel A. Fletcher et al.   NATURE

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

(2010) Vivian Barry-Hamilton et al.   NATURE MEDICINE

The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia

(2009) Ruth Schietke et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Six-Gene Signature Predicting Breast Cancer Lung Metastasis

(2008) T. Landemaine et al.   CANCER RESEARCH

The cell-cell adhesion molecule E-cadherin

(2008) F. van Roy et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

A two-tiered mechanism for stabilization and immobilization of E-cadherin

(2008) Matthieu Cavey et al.   NATURE

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE